Please assess the completion status of the following clinical trial:

Trial Title: Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented cancer~* Planned treatment with chemotherapy~* Age older than 18 years~* Informed consent~Exclusion Criteria:~* Heart failure (NYHA 3 and 4)~* Prior serious complications to blood transfusion~* Medical conditions that require special considerations for blood transfusion~* Treatment with erythropoiesis-stimulating agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Haemoglobin (<6.0 mmol/l) (Type: ACTIVE_COMPARATOR): Blood transfusion thresholds:Haemoglobin \< 6.0 mmol/l (9.9 g/dL)
- Haemoglobin (< normal range) (Type: EXPERIMENTAL): Blood transfusion threshold: Haemoglobin \< 7.1 mmol/l (11.7 g/dL) for female and 8.1 mmol/l (13.4 g/dL) for males

Based on this trial design, predict the completion outcome and termination type (if applicable).